1st Line NSCLC
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers (NCT05098132) | Synthekine | 2022-01-25 |
Track 1st Line NSCLC automatically
Every clearance here is in the API, with alerts when new ones post.